Search research articles
Contact Us
Filters
Showing results (261-270 of 295) with videos related to
Page
of 30
Sort By:
The American Journal of Surgical Pathology
|
December 10, 1999
Clear cell sarcoma of kidney in an adolescent and in young adults: a report of four cases with ultrastructural, immunohistochemical, and DNA flow cytometric analysis
M B Amin, M N de Peralta-Venturina, J Y Ro, et al.
Pancreas
|
January 1, 1990
Establishment of a new human pancreatic adenocarcinoma cell line, MDAPanc-3
M L Frazier, S Pathak, Z W Wang, et al.
Cancer
|
June 1, 1992
Sarcomatoid carcinoma of the prostate. A clinicopathologic study of 12 patients
R L Shannon, J Y Ro, D J Grignon, et al.
Annals of Internal Medicine
|
February 1, 1982
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion
S S Legha, R S Benjamin, B Mackay, et al.
Cancer
|
January 15, 1992
Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases
D J Grignon, J Y Ro, A G Ayala, et al.
Human Pathology
|
November 1, 1991
Paraganglioma of the urinary bladder: immunohistochemical, ultrastructural, and DNA flow cytometric studies
D J Grignon, J Y Ro, B Mackay, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing
|
August 28, 1998
Case study: The Washington State Health Care Authority
V M Wilson, C A Smith, J M Hamilton, et al.
Urologic Oncology
|
April 3, 2019
Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices
Shellie D Ellis, Mugur Geana, Christine B Mackay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1984
Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized study
M Valdivieso, M A Burgess, M S Ewer, et al.
Cancer
|
January 1, 1989
Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma
G N Hortobagyi, D Frye, A U Buzdar, et al.
Page
of 30
Search research articles
Search
Showing results (261-270 of 295) with videos related to
Sort By:
Page
of 30
The American Journal of Surgical Pathology
|
December 10, 1999
Clear cell sarcoma of kidney in an adolescent and in young adults: a report of four cases with ultrastructural, immunohistochemical, and DNA flow cytometric analysis
M B Amin, M N de Peralta-Venturina, J Y Ro, et al.
Pancreas
|
January 1, 1990
Establishment of a new human pancreatic adenocarcinoma cell line, MDAPanc-3
M L Frazier, S Pathak, Z W Wang, et al.
Cancer
|
June 1, 1992
Sarcomatoid carcinoma of the prostate. A clinicopathologic study of 12 patients
R L Shannon, J Y Ro, D J Grignon, et al.
Annals of Internal Medicine
|
February 1, 1982
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion
S S Legha, R S Benjamin, B Mackay, et al.
Cancer
|
January 15, 1992
Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases
D J Grignon, J Y Ro, A G Ayala, et al.
Human Pathology
|
November 1, 1991
Paraganglioma of the urinary bladder: immunohistochemical, ultrastructural, and DNA flow cytometric studies
D J Grignon, J Y Ro, B Mackay, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing
|
August 28, 1998
Case study: The Washington State Health Care Authority
V M Wilson, C A Smith, J M Hamilton, et al.
Urologic Oncology
|
April 3, 2019
Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices
Shellie D Ellis, Mugur Geana, Christine B Mackay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1984
Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized study
M Valdivieso, M A Burgess, M S Ewer, et al.
Cancer
|
January 1, 1989
Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma
G N Hortobagyi, D Frye, A U Buzdar, et al.
Page
of 30